A combination of low-dose systemic etretinate and topical calcipotriol/betamethasone dipropionate treatment for hyperkeratosis and itching in Olmsted syndrome associated with a TRPV3 mutation.
A combination of low-dose systemic etretinate and topical calcipotriol/betamethasone dipropionate treatment for hyperkeratosis and itching in Olmsted syndrome associated with a TRPV3 mutation.
复制标题
低剂量全身阿维A酯和局部卡泊三醇/二丙酸倍他米松联合治疗与 TRPV3 突变相关的奥姆斯特德综合征的角化过度和瘙痒。
DOI：
10.1016/j.jdermsci.2017.05.012
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Akiyama M.
中科院分区：
文献类型：
--
作者：
Takeichi T;Tsukamoto K;Okuno Y;Kojima D;Kono M;Suga Y;Akiyama M.
